SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001607062-17-000431
Filing Date
2017-12-12
Accepted
2017-12-12 07:52:29
Documents
6
Period of Report
2017-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A gnbt121117form8ka.htm 8-K/A 20915
2 EXHIBIT 99.1 exh99_1.htm EX-99.1 12362
3 EXHIBIT 10.1 ex10_1.htm EX-10.1 249896
4 GRAPHIC image_001.gif GRAPHIC 41212
5 GRAPHIC image_002.gif GRAPHIC 51869
6 GRAPHIC image_003.gif GRAPHIC 15932
  Complete submission text file 0001607062-17-000431.txt   434391
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K/A | Act: 34 | File No.: 000-25169 | Film No.: 171250880
SIC: 2834 Pharmaceutical Preparations